Can We Wait To Take The Economic Loss On Weight Loss
The Gist
Economic Evaluation of Health Improvements and Drug Pricing
Exploring the challenges and uncertainties faced by regulatory bodies in America and England when evaluating the economic worth of extending life in partial health, including discussions on valuing health improvements for conditions like diabetes and weight gain and pricing drugs for those in need.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
